Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference | ||||||||||||||||||
By: Nasdaq / GlobeNewswire - 14 Feb 2019 | Back to overview list |
|||||||||||||||||
LEXINGTON, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that Ronald Renaud, chief executive officer, will present in a session at the 8th Annual SVB Leerink Partners Global Healthcare Conference on Thursday, February 28, 2019, at 11:30 a.m. ET at the Lotte New York Palace in New York. A live webcast of the session will be accessible through the “Events and Presentations” page of the Company's website at investors.translate.bio. A replay of the webcast will be archived on the Company's website for 30 days following the presentation. About Translate Bio Contacts for Translate Bio
|
||||||||||||||||||
|
||||||||||||||||||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |